Microbix Biosystems Inc. (TSX:MBX)

Market Cap	33.25M -51.8%
Revenue (ttm)	16.76M -27.2%
Net Income	-4.27M
EPS	-0.03
Shares Out	138.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,699
Average Volume	38,817
Open	0.2400
Previous Close	0.2400
Day's Range	0.2400 - 0.2400
52-Week Range	0.2100 - 0.4600
Beta	0.38
RSI	55.97
Earnings Date	Feb 12, 2026

About Microbix Biosystems

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of p...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 70
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: MBX